Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
B A Teicher(Dana-Farber Cancer Institute), S D Liu(Guangxi Medical University), Ron Epelbaum(University of Bern), Terence S. Herman, S A Holden
PubMed
February 1, 1991
Cited by 42
Related Papers
Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279